<DOC>
	<DOCNO>NCT01307917</DOCNO>
	<brief_summary>Diabetes common metabolic disease childhood . Vascular disease lead complication diabetes , attempt maintain close glycemic control prevent sequela claim live quality life million diabetic year . Up forty percent patient diabetes mellitus ultimately develop diabetic nephropathy , common cause end-stage renal disease require dialysis US . Flavonoid-rich diet promise intervention prevent endothelial dysfunction apparently lead deadly complication . The mechanism still unclear probably involve nitric oxide synthesis . The investigator hypothesize early maintenance integrity renal vasculature significantly improve lifelong prognosis patient diabetes . Flavonoids anti-inflammatory antioxidant activity could use protect endothelial function , together good glycemic control , prevent development progression nephropathy . The investigator aim : 1. compare endothelial function study reactive hyperemia , nitric oxide , proinflammatory factor adolescent ( 12-21 year old ) diabetes versus healthy sex- age-matched control subject . 2. identify early marker urine vascular endothelial injury . 3. examine effect flavonoid vascular function , urine nitric oxide , proinflammatory factor patient diabetes mellitus .</brief_summary>
	<brief_title>Flavonoids Treatment Endothelial Dysfunction Children With Diabetes</brief_title>
	<detailed_description>Our proposal first attempt use flavonoid treat endothelial dysfunction causative factor nephropathy pediatric population diabetes . The investigator plan recruit 40 adolescent type 1 2 diabetes mellitus 40 healthy peer double-blind , randomize , control study . Peripheral arterial tonometry , noninvasive method ass vascular status , employ study endothelial function group . Measurements renal nitric oxide synthesis assay use nitric oxide chemiluminescence analyzer . Urinary protein microarray analysis conduct assess early marker kidney inflammation . The array multiplex sandwich fluorescent immunoassay simultaneous quantification interleukin-1b ( IL-1b ) , IL-2 , IL-4 , IL-6 , IL-8 , IL-10 , IL-12 , interferon gamma , tumor necrosis factor-alpha , macrophage inflammatory protein-1-alpha beta , RANTES . The initial acute response effect 14 day treatment flavonoid-rich capsulated supplement compare placebo . Study subject return baseline assessment week final flavonoid supplement evaluate sustainability response . Differences group mean measure variable , , intervention test statistical significance use pair t-tests nonparametric statistic . Univariate correlation calculate use Pearson 's r .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<criteria>adolescent 12 21 year old T1DM T2DM healthy age sexmatched peer DM subject must maintain good glycemic control HbA1C &lt; 11 comorbidities could lead inflammation decline renal function allow nonsteroidal antiinflammatory drug take , reason , within 48 hour prior study day smoke permitted day PreStudy Evaluation Study Days 0 , 14 , 21 control take medication</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>diabetes mellitus</keyword>
	<keyword>diabetic nephropathy</keyword>
	<keyword>vascular endothelial dysfunction</keyword>
	<keyword>flavonoid</keyword>
	<keyword>flow-mediated dilation</keyword>
</DOC>